Monographs: Dosage forms: Specific monographs: Isoniazid and ethambutol hydrochloride tablets (Isoniazidi et ethambutoli hydrochloridi compressi)

Category. Antituberculosis drugs.

Storage. Isoniazid and Ethambutol hydrochloride tablets should be kept in a tightly closed container.

Additional information. Strength in the current WHO Model list of essential medicines: 150 mg Isoniazid and 400 mg Ethambutol hydrochloride.

The tablets are usually film-coated.

Requirements

Comply with the monograph for "Tablets".

Definition. Isoniazid and Ethambutol hydrochloride tablets contain Isoniazid and Ethambutol hydrochloride. They contain not less than 90.0% and not more than 110.0% of the amounts of isoniazid (C6H7N3O) and ethambutol hydrochloride (C10H24N2O2,2HCl) stated on the label.

Identity tests

• Either test A or test B may be applied.

A. See the Assay described below. The retention times of the two principal peaks in the chromatogram obtained with solution (1) correspond to those in the chromatogram obtained with solution (2).

B. Carry out test B.1 or, where UV detection is not available, test B.2.

B.1 Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography, using silica gel R6 as the coating substance and a mixture of 100 volumes of methanol R and 1.5 volumes of strong ammonia solution R as the mobile phase. Apply separately to the plate 5 μl of each of the following two solutions in methanol R. For solution (A) shake a quantity of the powdered tablets containing about 5 mg of Isoniazid for 15 minutes with 5 mL of methanol R, filter, and use the filtrate. For solution (B) use 1 mg of isoniazid RS and 2.67 mg of ethambutol hydrochloride RS per mL of methanol R. After removing the plate from the chromatographic chamber, allow it to dry in a current of air, place in a chamber with iodine vapours, and allow to stand for 20 minutes. Examine the chromatogram immediately in ultraviolet light (254 nm).

The principal spots obtained with solution A correspond in position, appearance and intensity to those obtained with solution B.

B.2 Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography, using the conditions described above under test B.1 but using silica gel R5 as the coating substance. After removing the plate from the chromatographic chamber, allow it to dry in a current of air, place in a chamber with iodine vapours, and allow to stand for 20 minutes. Examine the chromatogram immediately in daylight.

The principal spots obtained with solution A correspond in position, appearance and intensity to those obtained with solution B.

Dissolution/Disintegration

• Either test A or test B may be applied

A. Dissolution. Carry out the test as described under 5.5 Dissolution test for solid oral dosage forms, using as the dissolution medium, 500 mL of dissolution buffer, pH 6.8, TS and rotating the paddle at 75 revolutions per minute. At 30 minutes withdraw a sample of 10 mL of the medium through an in-line filter. Allow the filtered sample to cool to room temperature and dilute 5 mL to 20 mL with water [solution (3)]. Determine the content of isoniazid (C6H7N3O) and ethambutol hydrochloride (C10H24N2O2,2HCl) as described below under Assay using solution (3) in place of solution (1).

For each of the six tablets tested, calculate the total amount of isoniazid (C6H7N3O) and ethambutol hydrochloride (C10H24N2O2,2HCl) in the medium from the results obtained. For both substances, the amount in solution for each tablet is not less than 80% of the amount declared on the label. For either substance, if the amount obtained for one of the six tablets is less than 80%, repeat the test using a further six tablets; the average amount for all 12 tablets tested is not less than 75% and the amount obtained for no tablet is less than 60%.

B. Disintegration. Comply with 5.3 Disintegration test for tablets and capsules, operating the apparatus for 10 minutes. If the tablets do not comply, carry out test A above.

Assay. Determine by 1.14.1 Chromatography, High-performance liquid chromatography, using a stainless steel column (15 cm x 4.6 mm) packed with particles of silica gel, the surface of which has been modified with chemically bonded octadecylsilyl groups (5 µm). As the mobile phase, use a solution prepared as follows: dissolve 50 g ammonium acetate R and 0.2 g copper(II) acetate R in 1000 mL of water and adjust to pH 5.0 with glacial acetic acid R. Mix 940 mL of this solution with 60 mL methanol R.

Prepare the following solutions in water. For solution (1) weigh and powder 20 tablets. Transfer a quantity of the powder containing about 100 mg Ethambutol hydrochloride, accurately weighed, to a 500-mL volumetric flask. Dissolve in about 400 mL of water R by shaking for about 15 minutes. [If foaming occurs, use 400 mL of a 4% solution of methanol R in place of the water.] Dilute to 500 mL with water R. Filter a portion of this solution through a 0.45-µm filter, discarding the first few mL of the filtrate. For solution (2) dissolve 100 mg of ethambutol hydrochloride RS and 37.5 mg of isoniazid RS in 500 mL of water R.

Operate with a flow rate of 2.0 mL per minute. As a detector use an ultraviolet spectrophotometer set at a wavelength of about 270 nm.

Inject alternately 20 µl each of solutions (1) and (2). (The peak for isoniazid is eluted at a retention time of about 1.6 minutes, and that for ethambutol hydrochloride at a retention time of about 6 minutes).

Measure the areas of the peak responses obtained in the chromatograms from solutions (1) and (2), and calculate the content of isoniazid (C6H7N3O) and ethambutol hydrochloride (C10H24N2O2,2HCl).

to previous sectionto next section